Christopher Chapman
2021
In 2021, Christopher Chapman earned a total compensation of $5.1M as President, Chief Medical Officer at Akers Biosciences, a 1,628% increase compared to previous year.
Compensation breakdown
| Bonus | $121,540 |
|---|---|
| Salary | $165,000 |
| Stock Awards | $4,854,000 |
| Total | $5,140,540 |
Chapman received $4.9M in stock awards, accounting for 94% of the total pay in 2021.
Chapman also received $121.5K in bonus and $165K in salary.
Rankings
In 2021, Christopher Chapman's compensation ranked 2,534th out of 12,415 executives tracked by ExecPay. In other words, Chapman earned more than 79.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,534 out of 12,415 | 80th |
Division Manufacturing | 1,009 out of 5,505 | 82nd |
Major group Chemicals And Allied Products | 386 out of 2,375 | 84th |
Industry group Drugs | 337 out of 2,096 | 84th |
Industry In Vitro and In Vivo Diagnostic Substances | 6 out of 61 | 90th |
Source: SEC filing on October 26, 2022.
Chapman's colleagues
We found three more compensation records of executives who worked with Christopher Chapman at Akers Biosciences in 2021.
News
Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M
November 1, 2024
Akers Biosciences CSO Adam Kaplin's 2022 pay falls 93% to $354K
June 30, 2023
Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M
October 26, 2022
Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M
November 22, 2021